Saltar al contenido
Merck

Trichloroethylene and Parkinson disease.

Neurologic clinics (2011-08-02)
Fariha Zaheer, John T Slevin
RESUMEN

Multiple genetic and environmental etiologies have been implicated in the pathogenesis of idiopathic Parkinson disease. Recent observations have suggested an association between chronic exposure to trichloroethylene (TCE) and development of clinical parkinsonism. Animal models of TCE exposure have shown nigrostriatal degeneration and the development of parkinsonian features. Animal and cell culture models indicate mitochondrial dysfunction as the probable mechanism, most likely mediated by TaClo, a potential TCE metabolite. These observations endorse the hypothesis that a variety of environmental risk factors may cause nigrostriatal degeneration and clinical parkinsonism in genetically predisposed individuals.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Trichloroethylene, ACS reagent, ≥99.5%
Supelco
Trichloroethylene solution, certified reference material, 5000 μg/mL in methanol
Supelco
Trichloroethylene, analytical standard, stabilized with 30 – 50 ppm Diisopropylamine
USP
Trichloroethylene solution, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Trichloroethylene, anhydrous, contains 40 ppm diisopropylamine as stabilizer, ≥99%